Bilcare Ltd526853Corporate

Healthcare Research, Analytics & Technology Latest results: Jun 2026 14 quarters of data

₹99.00

MCap ₹215 Cr

Bilcare Ltd — Stock analysis & AI research Bilcare Ltd — Live exchange announcements

AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.

₹2 Cr

Sales · Jun 2026

-6.3% YoY

₹-1 Cr

Operating Profit · Jun 2026

+29.8% YoY

-51.0%

OPM % · Jun 2026

+25.1% YoY

₹1 Cr

Net Profit · Jun 2026

-71.0% YoY

₹0.44

EPS · Jun 2026

-71.1% YoY

📝 Bilcare Ltd — results explained

Quarter ended June 2026 (Q1 FY27)

Bilcare Ltd reported revenue of ₹2 crore for the quarter ended June 2026 (Q1 FY27), down 6.3% from ₹2 crore in the same quarter last year, and up 61.7% sequentially over the March 2026 quarter.

Net profit fell 71.0% year-on-year to ₹1 crore, from ₹4 crore. Earnings per share (EPS) came in at ₹0.44.

Operating profit stood at ₹-1 crore — an operating margin (OPM) of -51.0%, compared with -68.1% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, Bilcare Ltd posted revenue of ₹7 crore, a decline of 54.7% over FY25, with a net profit of ₹1 crore (down 75.2% year-on-year).

On a trailing-twelve-month (TTM) basis, revenue stands at ₹7 crore with a net loss of ₹2 crore.

Valuation snapshot

At the current price of ₹99.00, 526853 has a market capitalisation of ₹215 crore.

Within the Healthcare Research, Analytics & Technology industry, it is the 5th-largest of the 10 companies we track by market value.

Shareholding pattern

As of Mar 2026, promoters held 30.01%, foreign institutional investors (FIIs) 0.04%, public shareholders 69.95% of Bilcare Ltd.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close

Valuation

Market Cap ?

₹215 Cr

Current Price ?

₹99.0

P/E ?

N/A

Industry P/E ?

35.60

P/B ?

0.51

P/S ?

31.93

P/FCF ?

15.66

Enterprise Value ?

₹226 Cr

EV/EBITDA ?

-18.76

PEG ?

N/A

Earnings Yield ?

-6.5%

Dividend Yield ?

0.00%

Profitability & Returns

Sales (TTM) ?

₹7 Cr

OPM ?

-179.6%

Profit after tax (TTM) ?

₹-2 Cr

EPS (TTM) ?

₹-0.72

ROCE ?

1.0%

ROE ?

-0.4%

ROA ?

-0.3%

Growth

Sales — latest qtr ?

₹2 Cr

PAT — latest qtr ?

₹1 Cr

YoY qtr sales growth ?

-6.3%

YoY qtr profit growth ?

-71.0%

Sales growth (3y) ?

-21%

Sales growth (5y) ?

-53%

Profit growth (3y) ?

32%

Profit growth (5y) ?

15%

Financial Health

Debt ?

₹12 Cr

Debt to Equity ?

0.03

Interest Coverage ?

-25.3

Current Ratio ?

N/A

Ownership

Promoter holding ?

30.01%

Change in promoter holding ?

0.00%

Pledged percentage ?

N/A

Market

Return 3 months ?

76.2%

Return 6 months ?

72.7%

🗓️ Quarterly results (14 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best Highlight

Metric	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	YoY %	QoQ %
Sales	5	4	5	5	4	5	3	3	4	2	2	2	1	2	-6.3%	+61.7%
Operating Profit	-6	-1	-2	-1	-4	-1	-3	-1	-2	-1	-1	-2	-8	-1	+29.8%	+87.6%
Other Income	518	16	-2	0	5	4	4	4	6	7	3	5	2	4	-35.1%	+150.6%
Interest	0	0	0	0	2	1	3	0	0	0	0	0	0	0	-14.3%	-14.3%
Depreciation	2	0	1	1	1	1	1	1	1	1	1	1	1	1	-11.8%	-1.6%
Profit Before Tax	510	14	-4	-2	-2	2	-3	2	4	4	1	3	-7	1	-79.7%	+113.0%
Net Profit	394	13	-4	-2	-2	1	-3	2	3	4	1	3	-6	1	-71.0%	+116.4%
EPS	167.35	5.70	-1.72	-0.66	-1.06	0.59	-1.09	0.77	1.43	1.52	0.44	1.15	-2.70	0.44	-71.1%	+116.3%
OPM %	-136.1%	-39.6%	-44.7%	-24.1%	-102.3%	-17.5%	-98.9%	-15.5%	-38.0%	-68.1%	-73.5%	-100.6%	-665.0%	-51.0%	+25.1%	+92.3%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric	FY25	FY26	TTM	YoY %
Sales	₹15 Cr	₹7 Cr	₹7 Cr	-54.7%
Operating Profit	₹-6 Cr	₹-12 Cr	₹-12 Cr	-120.3%
OPM %	-37.50%	-182.34%	-179.61%	-386.2%
NPM %	26.46%	14.45%	-23.21%	-45.4%
Other Income	₹18 Cr	₹17 Cr	₹15 Cr	-2.7%
Depreciation	₹3 Cr	₹3 Cr	₹3 Cr	-5.2%
Interest	₹4 Cr	₹1 Cr	₹1 Cr	-84.4%
EBIT	₹-9 Cr	₹-15 Cr	₹-15 Cr	-78.1%
PBT	₹5 Cr	₹2 Cr	₹-2 Cr	-71.4%
Tax	—	—	₹-0 Cr	—
Net Profit	₹4 Cr	₹1 Cr	₹-2 Cr	-75.2%
EPS	₹1.70	₹0.41	₹-0.67	-75.9%
Material Cost	—	—	₹1 Cr	—
Employee Cost	—	—	₹1 Cr	—
Extraordinary Items	—	—	₹-2 Cr	—

🏛️ Balance Sheet (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Equity Capital	23.55	23.55	23.55	23.55	+0.0%
Reserves	386.86	392.11	396.13	397.34	+0.3%
Borrowings	7.52	10.29	10.82	11.87	+9.7%
Other Liabilities	36.24	34.54	21.72	22.36	+2.9%
Total Liabilities	454.17	460.49	452.22	455.12	+0.6%
Fixed Assets	16.25	63.41	60.61	57.62	-4.9%
CWIP	0.00	0.00	0.00	0.00	—
Investments	293.51	293.52	293.52	309.71	+5.5%
Other Assets	144.41	103.56	98.09	87.79	-10.5%
Total Assets	454.17	460.49	452.22	455.12	+0.6%

💧 Cash Flow (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Cash from Operating Activity	397.43	97.63	2.36	11.57	+390.3%
Cash from Investing Activity	180.97	-107.06	2.94	-14.05	-577.9%
Cash from Financing Activity	-570.93	-0.51	-3.85	0.24	+106.2%
Net Cash Flow	7.47	-9.94	1.45	-2.24	-254.5%
Free Cash Flow	791.28	-10.14	4.98	13.70	+175.1%
CFO/OP	-5,581%	-1,065%	-21%	-105%	-400.0%

➗ Ratios (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Debtor Days	246.73	101.41	82.32	108.70	+32.0%
Inventory Days	60.10	21.27	30.02	37.12	+23.7%
Days Payable	439.03	91.35	154.06	435.11	+182.4%
Cash Conversion Cycle	-132.20	31.33	-41.72	-289.29	-593.4%
Working Capital Days	-640.97	1,135.23	1,529.52	2,540.61	+66.1%
ROCE %	-1.38%	-1.97%	1.58%	1.00%	-36.7%

👥 Shareholding (latest 4 periods)

Metric	Jun 2025	Sep 2025	Dec 2025	Mar 2026	% Chg
Promoters	30.01%	30.01%	30.01%	30.01%	+0.0%
FIIs	0.04%	0.04%	0.04%	0.04%	+0.0%
Public	69.95%	69.94%	69.95%	69.95%	+0.0%
No. of Shareholders	17,047	16,513	16,068	15,824	-1.5%

⚖️ Peer comparison

Industry: Healthcare Research, Analytics & Technology · 10 companies · full page →

#	Company	CMP	MCap (Cr)	P/E	Sales TTM	NP TTM	OPM%	NPM%	Sales YoY%	NP YoY%	Qtr Rev Δ%	Qtr NP Δ%
1	INDGN Indegene	₹597.05	14,377	35.8	3,812	401	16.7%	10.5%	23.6%	-1.5%	39.7%	-0.2%
2	SUVEN Suven Life	₹286.25	8,088	—	9	-353	-3955.0%	-3815.2%	6.9%	-71.9%	114.3%	-148.5%
3	VIMTALABS Vimta Labs	₹637.20	2,847	35.7	419	80	34.4%	19.1%	18.0%	19.5%	11.3%	10.7%
4	FABTECH Fabtech Technologies	₹145.66	647	44.8	364	14	2.4%	4.0%	—	—	10.3%	168.7%
5	526853 Bilcare Ltd-$	₹61.25	215	—	773	-6	9.1%	-0.8%	-6.9%	36.7%	21.2%	253.4%
6	TAKE Take Solutions	₹12.69	186	14.6	85	13	-2.0%	15.2%	—	-71.0%	—	216.8%
7	536565 Novelix Pharmaceuticals	₹19.88	181	13.2	147	4	3.1%	2.5%	330.7%	2218.2%	65.2%	971.7%
8	538837 Jeevan Scientific	₹50.96	178	22.6	71	5	20.5%	7.2%	31.4%	1371.4%	107.7%	127.0%
9	543309 Adeshwar Meditex	₹27.50	24	31.2	56	1	4.9%	2.2%	—	—	-30.4%	-60.4%
10	540729 Vanta Bioscience	₹51.45	15	333.1	2	0	55.8%	6.1%	—	—	357.6%	240.9%

❓ Frequently asked questions

What was Bilcare Ltd's revenue in Q1 FY27?